USA Financial Portformulas Corp lowered its position in UnitedHealth Group (NYSE:UNH) by 30.7% in the 4th quarter, Holdings Channel reports. The firm owned 26,500 shares of the healthcare conglomerate’s stock after selling 11,748 shares during the period. UnitedHealth Group comprises about 1.4% of USA Financial Portformulas Corp’s portfolio, making the stock its 15th largest holding. USA Financial Portformulas Corp’s holdings in UnitedHealth Group were worth $5,842,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently made changes to their positions in the company. Exane Derivatives increased its holdings in UnitedHealth Group by 15,333.3% during the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after buying an additional 460 shares during the last quarter. Aevitas Wealth Management Inc. purchased a new stake in UnitedHealth Group during the fourth quarter worth about $102,000. Pathstone Family Office LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth about $129,000. Trustcore Financial Services LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth about $133,000. Finally, Intellectus Partners LLC increased its holdings in UnitedHealth Group by 18.2% during the second quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock worth $152,000 after buying an additional 126 shares during the last quarter. Institutional investors own 86.78% of the company’s stock.
In other UnitedHealth Group news, insider Larry C. Renfro sold 22,184 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the sale, the insider now directly owns 173,229 shares in the company, valued at $39,659,047.26. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, March 19th. The shares were sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the sale, the director now owns 1,771,257 shares of the company’s stock, valued at $397,399,220.52. The disclosure for this sale can be found here. Insiders sold 77,015 shares of company stock valued at $17,879,199 over the last 90 days. 0.89% of the stock is owned by company insiders.
A number of analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $254.00 price objective for the company. in a report on Friday. Cantor Fitzgerald reiterated a “buy” rating and set a $280.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 8th. Citigroup increased their target price on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Oppenheimer increased their target price on shares of UnitedHealth Group from $260.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, Deutsche Bank increased their target price on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $244.62.
UNH stock opened at $230.32 on Tuesday. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group has a 12 month low of $164.96 and a 12 month high of $250.79. The company has a market capitalization of $217,027.44, a PE ratio of 22.87, a PEG ratio of 1.31 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same period last year, the business earned $2.11 earnings per share. UnitedHealth Group’s revenue was up 9.5% compared to the same quarter last year. equities research analysts predict that UnitedHealth Group will post 12.52 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were given a $0.75 dividend. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.30%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 29.79%.
COPYRIGHT VIOLATION NOTICE: This article was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was stolen and reposted in violation of international trademark and copyright laws. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/17/usa-financial-portformulas-corp-has-5-84-million-stake-in-unitedhealth-group-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.